Pneumonia Patients Taking Ticagrelor Became Less Reliant on Supplemental Oxygen
Supplemental oxygen requirements were recorded from patient records. Data were collected at the time closest to when the patient received the study medication and 24 and 48 h following study dosage. Supplemental oxygen was recorded as none (room air), nasal cannula, and high-flow (HF) devices and mechanical ventilation. Patients randomized to ticagrelor demonstrated a progression to room air and away from supplemental oxygen (odds ratio [OR]: 1.08; 95% confidence interval [CI]: 1.01 to 1.15). Patients randomized to placebo did not change over 48 h after receiving the study dose (OR: 0.99; 95% CI: 0.95 to 1.04).